Given its influence over various oncogenic mechanisms including the PI3K/AKT, EGFR, Src, and WNT pathways, AR dysregulation plays crucial roles in promoting the proliferation and progression of certain cancers such as prostate, breast, liver, and ovarian malignancies [63, 64]. The gene discussed is EGFR; the disease is cancer.